Individualizing Care for Patients With Triple-Negative Breast Cancer

CCO Oncology Podcast

Content provided by Clinical Care Options, LLC and Clinical Care Options. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Clinical Care Options, LLC and Clinical Care Options or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

1+ y ago 36:17

MP3•Episode home

In this podcast episode from a live CCO Cancer Conversations webinar, Mark Pegram, MD, and Sara Tolaney, MD, MPH, provide expert perspectives on optimal treatment strategies for patients with triple-negative breast cancer (TNBC), with topics including:

Current data and strategies for using PD-1/PD-L1 inhibitors in early-stage TNBC
Clinical implications of PD-L1 status on therapeutic planning for patients with metastatic TNBC
Current data and treatment strategies and the future of antibody–drug conjugates in the management of relapsed/refractory advanced TNBC
Treatment implications of the presence of BRCA1/2 mutations and homologous recombination deficiency genes in advanced TNBC
Role of PARP inhibitors in the treatment of TNBC

Presenters:

Mark Pegram, MD
Professor
Medical Oncology
Stanford University
Palo Alto, California

Sara Tolaney, MD, MPH
Associate Professor of Medicine
Division of Breast Oncology
Harvard Medical School
Chief, Division of Breast Oncology
Breast Oncology Program
Dana-Farber Cancer Institute
Boston, Massachusetts

Content based on an online CME/CE/CPE program supported by educational grants from Gilead Sciences, Inc.

Link to full program:
http://bit.ly/3iQzDz5

175 episodes

#Science #Fitness #Biology #Higher Education #Podcasting Education #Medicine #Clinical Care Options, LLC #Clinical Care Options #Essential Thrombocythemia #Myelofibrosis #Oncology #CME #Nonmalignant Hematological Disorders #Skin Cancer #Hematological Malignancies #Acute Myeloid Leukemia #Kidney Cancer #Melanoma #Gastrointestinal Cancer #Acute Lymphocytic Leukemia #Prostate Cancer #Myeloproliferative Neoplasms #Follicular Lymphoma #Glioblastoma #Nsclc #Multiple Myeloma #Hodgkin Lymphoma #Basal Cell Carcinoma #All #Polycythemia Vera #Breast Cancer #Dlbcl #Head And Neck Cancer #Liver Cancer #Sarcoma #Gastroesophageal Cancer #Lung Cancer #Hepatocellular Carcinoma #Urothelial Carcinoma #Cancer Screening #Renal Cell Carcinoma #AML #Ovarian Cancer #CPE #Lymphoma #Diffuse Large B-cell Lymphoma #Cll #Pancreatic Cancer #Beta-thalassemia #Chronic Myeloid Leukemia